🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Structure Therapeutics Inc.

GPCR Healthcare
$53.48 +$3.31 (6.60%)
Market Cap: $3.79 B
Gurus Holding
3
Popularity Rank
#2664
% of Shares Held
0.36%
Net Activity (Q4 2025)
-$16.35 M

Guru Ownership Trend

Guru Analysis for Structure Therapeutics Inc. (GPCR)

Structure Therapeutics Inc. (GPCR), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $13.54 M.

Top institutional holders include Renaissance Technologies (RenTech) and Jefferies Group.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $16.35 M net outflow during the quarter.

Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Jefferies Group reduced exposure by 39.5%.

Key Holders

Recent Activity Breakdown (Q4 2025)

+$2.44 M
Total Buy Value
New Buys 1
Additions 0
-$18.79 M
Total Sell Value
Reductions 2
Sold Out 1

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
3
Net Buyers
1

FAQs for Structure Therapeutics Inc. (GPCR)

Major holders include Renaissance Technologies (RenTech) ($8.01 M), Jefferies Group ($7.16 M), Paul Tudor Jones ($2.44 M). According to the latest reported data, 3 tracked investment managers collectively hold approximately 253,246 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $16.35 M, with 1 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited GPCR. The total reported sell value was $18.79 M.

Yes, 1 managers opened new positions in GPCR, and 0 increased their existing holdings. The total reported buy value was $2.44 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% Reduce -25.2% 115,200 $8.01 M Q4 2025
0.04% Reduce -39.5% 102,993 $7.16 M Q4 2025
0.00% New Buy 35,053 $2.44 M Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form